Advertising Age Article Abstract
New Facebook Policy Spurs Big Pharma to Rethink Social Media Strategy
Major Marketers Fear that Enabling Comments Will Attract FDA Ire
Pharmaceutical marketers are trying hard to embrace social media, but the very nature of the two-way dialogue endemic to the medium threatens to work against them. Case in point: Facebook's new poliicy. ...

